Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy

Clicks: 111
ID: 118356
2017
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #363 of 438 articles by views in acta neuropathologica

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 438 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Sporadic cerebral amyloid angiopathy (CAA) is characterized by cerebrovascular amyloid beta (Aβ) deposits and causes cerebral hemorrhage and dementia. The exact molecules that co-accumulate with cerebrovascular Aβ deposits are still not fully known. In our study here, we performed proteomic analyses with microdissected leptomeningeal arteries and cerebral neocortical arterioles from 8 cases with severe CAA, 12 cases with mild CAA, and 10 control cases without CAA, and we determined the levels of highly expressed proteins in cerebral blood vessels in CAA. We focused on sushi repeat-containing protein 1 (SRPX1), which is specifically expressed in CAA-affected cerebral blood vessels. Because SRPX1, which is known as a tumor suppressor gene, reportedly induced apoptosis in tumor cells, we hypothesized that SRPX1 may play an important role in Aβ-induced apoptosis in CAA. Immunohistochemical studies revealed that SRPX1 co-accumulated with Aβ deposits in cerebral blood vessels of all autopsied cases with severe CAA. In contrast, no SRPX1 co-accumulated with Aβ deposits in senile plaques. Furthermore, we demonstrated that both Aβ40 and Aβ42 bound to SRPX1 in vitro and enhanced SRPX1 expression in primary cultures of cerebrovascular smooth muscle cells. SRPX1 enhanced caspase activity induced by Aβ40. Knockdown of SRPX1, in contrast, reduced the formation of Aβ40 accumulations and the activity of caspase in cultured cerebrovascular smooth muscle cells. SRPX1 may thus be a novel molecule that is up-regulated in cerebrovascular Aβ deposits and that may increase Aβ-induced cerebrovascular degeneration in CAA.
Reference Key
inoue2017actasushi Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Yasuteru Inoue;Mitsuharu Ueda;Masayoshi Tasaki;Akari Takeshima;Akihito Nagatoshi;Teruaki Masuda;Yohei Misumi;Takayuki Kosaka;Toshiya Nomura;Mayumi Mizukami;Sayaka Matsumoto;Taro Yamashita;Hitoshi Takahashi;Akiyoshi Kakita;Yukio Ando;Yasuteru Inoue;Mitsuharu Ueda;Masayoshi Tasaki;Akari Takeshima;Akihito Nagatoshi;Teruaki Masuda;Yohei Misumi;Takayuki Kosaka;Toshiya Nomura;Mayumi Mizukami;Sayaka Matsumoto;Taro Yamashita;Hitoshi Takahashi;Akiyoshi Kakita;Yukio Ando;
Journal acta neuropathologica
Year 2017
DOI
doi:10.1007/s00401-017-1720-z
URL
https://link.springer.com/article/10.1007/s00401-017-1720-z
Keywords
pathology neurosciences

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.